Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$234000.0.

  • Harvard Bioscience's Other Working Capital Changes rose 8612.1% to -$234000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year increase of 5542.89%. This contributed to the annual value of -$1.6 million for FY2024, which is 54.51% up from last year.
  • Latest data reveals that Harvard Bioscience reported Other Working Capital Changes of -$234000.0 as of Q3 2025, which was up 8612.1% from -$308000.0 recorded in Q2 2025.
  • Harvard Bioscience's Other Working Capital Changes' 5-year high stood at $1.7 million during Q2 2021, with a 5-year trough of -$2.3 million in Q4 2023.
  • For the 5-year period, Harvard Bioscience's Other Working Capital Changes averaged around -$227526.3, with its median value being -$135000.0 (2021).
  • Per our database at Business Quant, Harvard Bioscience's Other Working Capital Changes surged by 1034313.8% in 2021 and then plummeted by 16635.07% in 2024.
  • Harvard Bioscience's Other Working Capital Changes (Quarter) stood at -$1.6 million in 2021, then fell by 7.83% to -$1.7 million in 2022, then plummeted by 33.92% to -$2.3 million in 2023, then skyrocketed by 66.36% to -$769000.0 in 2024, then soared by 69.57% to -$234000.0 in 2025.
  • Its last three reported values are -$234000.0 in Q3 2025, -$308000.0 for Q2 2025, and -$97000.0 during Q1 2025.